Key Finding:
Metabolic and immune response pathways are differentially regulated between BRCA1 mutant, BRCA2 mutant, and homologous recombination wild-type high-grade serous ovarian cancers.
Publications
Exploring the nuances between BRCA1 and 2: a multiomic analysis
– Caris Life Sciences
Download Publication